$1.48
0.68%
Nasdaq, Aug 22, 10:17 pm CET
ISIN
US69353Y1038
Symbol
PMVP

PMV Pharmaceuticals Inc Stock price

$1.48
+0.21 16.54% 1M
+0.05 3.50% 6M
-0.03 1.99% YTD
-0.05 3.27% 1Y
-12.20 89.18% 3Y
-16.52 91.78% 5Y
-16.52 91.78% 10Y
-16.52 91.78% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.01 0.68%
ISIN
US69353Y1038
Symbol
PMVP
Industry

Key metrics

Basic
Market capitalization
$78.4m
Enterprise Value
$-63.8m
Net debt
positive
Cash
$142.3m
Shares outstanding
53.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.9
P/B
0.6
Financial Health
Equity Ratio
92.1%
Return on Equity
-33.3%
ROCE
-64.8%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-91.0m | $-98.2m
EBIT
$-91.5m | $-92.4m
Net Income
$-80.9m | $-61.8m
Free Cash Flow
$-70.1m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-20.6% | -16.5%
EBIT
-18.9% | -8.2%
Net Income
-65.4% | -5.3%
Free Cash Flow
-51.3%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-1.6
FCF per Share
$-1.3
Short interest
1.8%
Employees
47
Rev per Employee
$0.0
Show more

Is PMV Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

PMV Pharmaceuticals Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a PMV Pharmaceuticals Inc forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a PMV Pharmaceuticals Inc forecast:

Buy
91%
Hold
9%

Financial data from PMV Pharmaceuticals Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 25 25
13% 13%
-
- Research and Development Expense 67 67
21% 21%
-
-91 -91
21% 21%
-
- Depreciation and Amortization 0.48 0.48
67% 67%
-
EBIT (Operating Income) EBIT -91 -91
19% 19%
-
Net Profit -81 -81
65% 65%
-

In millions USD.

Don't miss a Thing! We will send you all news about PMV Pharmaceuticals Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PMV Pharmaceuticals Inc Stock News

Neutral
The Motley Fool
18 days ago
PMV Pharmaceuticals (PMVP) Q2 Loss Jumps
Neutral
GlobeNewsWire
18 days ago
PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today reported financial results for the second quarter ended June 30, 2025, and provided a corporate update.
Neutral
GlobeNewsWire
3 months ago
PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Officer and Deepika Jalota, Pharm. D., Chief Development Officer, will participate at the...
More PMV Pharmaceuticals Inc News

Company Profile

PMV Pharmaceuticals, Inc. engages in the development of p53 targeted small molecule drugs for the treatment of cancer. It combines unique biological understanding with pharmaceutical development focus. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in 2013 and is headquartered in New Jersey, NY.

Head office United States
CEO David Mack
Employees 47
Founded 2013
Website www.pmvpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today